z-logo
open-access-imgOpen Access
Mechanism of genistein regulating the differentiation of vascular smooth muscle cells into osteoblasts via the OPG/RANKL pathway
Author(s) -
Cheng Shen,
Ye Yuan,
Fuping Li,
Yijie Hu,
Yi Song,
Shulin Zhao,
Qianjin Zhong
Publication year - 2017
Publication title -
oncotarget
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.373
H-Index - 127
ISSN - 1949-2553
DOI - 10.18632/oncotarget.20167
Subject(s) - rankl , genistein , vascular smooth muscle , microbiology and biotechnology , mechanism (biology) , osteoblast , medicine , signal transduction , cancer research , osteoprotegerin , endocrinology , chemistry , smooth muscle , biology , receptor , biochemistry , activator (genetics) , in vitro , philosophy , epistemology
The present study aimed to investigate the mechanism of genistein, a tyrosine kinase inhibitor, regulating the differentiation of vascular smooth muscle cells (VSMCs) into osteoblasts via the OPG/RANKL (Osteoprotegerin/Receptor Activator of Nuclear Factor-κB Ligand) pathway.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom